Jackson Financial (JXN) has quietly caught investor interest again with its recent price action, even though there is no single headline-making event behind the movement. In moments like this, it is worth pausing to consider what the market might be signaling about the company’s fundamentals or its potential in an evolving environment. Sometimes, a stock’s move without obvious news can be just as telling as a major announcement. Looking back, Jackson Financial’s performance stands out. Shares are up 20% over the past year and they have advanced another 20% in the past 3 months alone, suggesting growing momentum. While there is no dramatic event to point to, the combination of accelerating returns and solid annual revenue growth hints that investors could be seeing value or anticipating improved business conditions. Recent earnings show healthy revenue growth, even as net income remains under pressure. Given the current run-up, the key question is whether Jackson Financial is now undervalued, or if investors have already priced in every bit of potential growth.

The most widely followed narrative suggests that Jackson Financial enjoys a modest undervaluation, with its current share price sitting slightly below analyst estimates of fair value. The consensus reflects optimism that recent performance and strategic factors can support further upside.

The strategic shift toward greater product diversification, especially fee-based and spread products such as RILA and fixed annuities, is expanding Jackson's margins, reducing earnings volatility, and positioning the company to benefit from long-term trends in defined contribution retirement plans. This, in turn, is positively impacting net margins and overall profitability.

Thinking about what really justifies this valuation? The secret lies in the assumptions that analysts built into these price targets. Behind the surface are projections of growing profits, rising margins, and a future profit multiple that may catch you off guard. Wondering what exactly powers this narrative and separates Jackson from the crowd? The full story includes optimistic forecasts and a few surprising numbers that are not obvious at first glance.

Result: Fair Value of $103 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, persistent net outflows in variable annuities or a broad shift away from annuities could present challenges to Jackson's growth and put pressure on margins in the future.

Find out about the key risks to this Jackson Financial narrative.

Looking at things from another angle, our DCF model points to a significantly larger gap between Jackson Financial’s share price and its estimated value. This raises new questions about just how much value the market is overlooking.

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Jackson Financial for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

If you see the story differently or want to run the numbers your own way, you can quickly craft your personal version in just minutes. Do it your way

A great starting point for your Jackson Financial research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.

Take the next step toward your investing goals by uncovering compelling companies with the potential to outperform. New opportunities are waiting, so do not let them pass you by.

Spot overlooked bargains with strong financials by checking out undervalued stocks based on cash flows that could offer value others have missed.

Target steady income streams and boost your portfolio’s resilience by exploring 3%;elm:context_link;itc:0;sec:content-canvas\\" class=\\"link \\">dividend stocks with yields > 3% offering yields over 3%.

Be ahead of tomorrow’s breakthroughs by uncovering future game-changers in medical innovation through healthcare AI stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include JXN.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com